Artificial Intelligence-based Coronary Stenosis Quantification at Coronary CT Angiography versus Quantitative Coronary Angiography.

CT Angiography Cardiac Coronary Arteries

Journal

Radiology. Cardiothoracic imaging
ISSN: 2638-6135
Titre abrégé: Radiol Cardiothorac Imaging
Pays: United States
ID NLM: 101748663

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 3 1 2024
pubmed: 3 1 2024
entrez: 2 1 2024
Statut: ppublish

Résumé

Purpose To evaluate the performance of a new artificial intelligence (AI)-based tool by comparing the quantified stenosis severity at coronary CT angiography (CCTA) with a reference standard derived from invasive quantitative coronary angiography (QCA). Materials and Methods This secondary, post hoc analysis included 120 participants (mean age, 59.7 years ± 10.8 [SD]; 73 [60.8%] men, 47 [39.2%] women) from three large clinical trials (AFFECTS, P3, REFINE) who underwent CCTA and invasive coronary angiography with QCA. Quantitative analysis of coronary stenosis severity at CCTA was performed using an AI-based coronary stenosis quantification (AI-CSQ) software service. Blinded comparison between QCA and AI-CSQ was measured on a per-vessel and per-patient basis. Results The per-vessel AI-CSQ diagnostic sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 80%, 88%, 86%, 65%, and 94%, respectively, for diameter stenosis (DS) 50% or greater; and 78%, 92%, 91%, 47%, and 98%, respectively, for DS 70% or greater. The areas under the receiver operating characteristic curve (AUCs) to predict DS of 50% or greater and 70% or greater on a per-vessel basis were 0.92 (95% CI: 0.88, 0.95;

Identifiants

pubmed: 38166336
doi: 10.1148/ryct.230124
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e230124

Auteurs

James Dundas (J)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Jonathon A Leipsic (JA)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Stephanie Sellers (S)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Philipp Blanke (P)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Patricia Miranda (P)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Nicholas Ng (N)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Sarah Mullen (S)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

David Meier (D)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Mariama Akodad (M)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Janarthanan Sathananthan (J)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Carlos Collet (C)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Bernard de Bruyne (B)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Olivier Muller (O)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Georgios Tzimas (G)

From the Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.D., J.A.L., P.B., G.T.); Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation & Providence Research, Vancouver, British Columbia, Canada (S.S.); HeartFlow, Mountain View, Calif (P.M., N.N., S.M.); Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada (D.M., J.S.); Interventional Cardiology Department, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France (M.A.); OLV Clinic, Cardiovascular Center Aalst, Aalst, Belgium (C.C., B.d.B.); and Department of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland (O.M., G.T.).

Classifications MeSH